Overall survival of 126 patients with multiple myeloma as a function of ALC recovery at day 15 after ASCT.

Median overall survival time for patients with an ALC greater than or equal to 500 cells/μL was 33 months versus 12 months for patients with an ALC less than 500 cells/μL (P < .0001).